Zusammenfassung
Pruritus ist definiert als ein Symptom, das zum Kratzen führt. Klinisch ist eine heterogene Gruppe von Krankheitsbildern unterschiedlicher Ätiologie zu berücksichtigen. Pruritus ist durch unterschiedliche Intensität und Dauer charakterisiert. Die Beeinflussung der Schlafqualität wird von vielen Patienten und/oder ihrem sozialen Umfeld, das dadurch mitbeeinflusst ist, als ein begleitendes Hauptsymptom angeführt. Die Lebensqualität der Patienten ist je nach Schweregrad des Pruritus beeinflusst und führt nicht selten bei Chronifizierung zu Komorbidität wie depressive Störungen oder Schlafstörungen sowie zur Beeinflussung des psychosozialen Wohlbefindens. Bislang sind neben der Anamnese die Ermittlung der Krankheitslast durch Erhebung der Krankheitsaktivität z. B. mit validierten krankheitsspezifischen Scores plus die Erfassung der Lebensqualität durch einen dermatologischen Lebensqualitätsindex (Dermatology Life Quality Index [DLQI]) die etablierten Untersuchungsmethoden. Neueste Untersuchungen zeigen, dass dies keinesfalls ausreicht, um die Erkrankungsschwere zu eruieren und daraus resultierend adäquate Therapieoptionen zu ermitteln.
Abstract
Pruritus is defined as a symptom that leads to scratching. Clinically, a heterogeneous group of clinical pictures of different etiology must be considered. Pruritus is characterized by varying intensity and duration. Many patients and/or their social environment, which is influenced by this, cite the impact on sleep quality as an accompanying main symptom. The patient’s quality of life is affected depending on the severity of the pruritus and often leads to comorbidity such as depressive disorders or sleep disorders as well as to an impact on psychosocial well-being if it becomes chronic. To date, in addition to the medical history, the established examination methods have been the determination of the disease burden by assessing disease activity, e.g., with validated disease-specific scores, plus the assessment of quality of life using a dermatological quality of life index (DLQI). The latest studies show that this is by no means sufficient to determine the severity of disease and, as a result, to identify adequate treatment options.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00105-024-05373-0/MediaObjects/105_2024_5373_Fig1_HTML.png)
Literatur
Ständer S, Zeidler C, Augustin M et al (2022) S2k Leitlinie: Diagnostik und Therapie des chronischen Pruritus. J Dtsch Dermatol Ges 20(10):1386–1402. https://doi.org/10.1111/ddg.14830_g
Birkner T, Siegels D, Heinrich L et al (2023) Itch, sleep loss, depressive symptoms, fatigue, and productivity loss in patients with moderate-to-severe atopic dermatitis: analyses of TREATgermany registry data. J Dtsch Dermatol Ges 21(10):1157–1168. https://doi.org/10.1111/ddg.15159
Weisshaar E, Ständer S, Gieler U, Matterne U, Darsow U (2011) Development of a German language questionnaire for assessing chronic pruritus (AGP-questionnaire): background and first results. Hautarzt 62(12):914–927. https://doi.org/10.1007/s00105-011-2236-4
Finlay AY, Khan GK (1994) Dermatology life quality index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol 19(3):210–216. https://doi.org/10.1111/j.1365-2230.1994.tb01167.x
Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY (2005) Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 125(4):659–664. https://doi.org/10.1111/j.0022-202X.2005.23621.x
Krause K, Kessler B, Weller K et al (2013) German version of ItchyQoL: validation and initial clinical findings. Acta Derm Venereol 93(5):562–568. https://doi.org/10.2340/00015555-1544
Mann C, Dreher M, Weeß HG, Staubach P (2020) Sleep disturbance in patients with urticaria and atopic dermatitis: an underestimated burden. Acta Derm Venereol 100(6):adv73. https://doi.org/10.2340/00015555-3416
Kaaz K, Szepietowski JC, Matusiak Ł (2019) Influence of itch and pain on sleep quality in atopic dermatitis and psoriasis. Acta Derm Venereol 99(2):175–180. https://doi.org/10.2340/00015555-3065
Mann C, Dreher M, Rothschmidt JN, Staubach P (2024) Burden of impaired sleep and its improvement through topical treatment in psoriasis and atopic dermatitis. J Dtsch Dermatol Ges. https://doi.org/10.1111/ddg.15373
Iber C, Ancoli-Israel S, Chesson A, Quan S (2008) Das AASM-Manual zum Scoring von Schlaf und assoziierten Ereignissen: Regeln, Terminologie und technische Spezifikationen
Carley DW, Farabi SS (2016) Physiology of sleep. Diabetes Spectr 29(1):5–9. https://doi.org/10.2337/diaspect.29.1.5
Monti JM, Vignale R, Monti D (1989) Sleep and nighttime pruritus in children with atopic dermatitis. Sleep 12(4):309–314. https://doi.org/10.1093/sleep/12.4.309
Hossain JL, Shapiro CM (2002) The prevalence, cost implications, and management of sleep disorders: an overview. Sleep Breath 6(2):85–102. https://doi.org/10.1007/s11325-002-0085-1
McArdle N, Ward SV, Bucks RS et al (2020) The prevalence of common sleep disorders in young adults: a descriptive population-based study. Sleep. https://doi.org/10.1093/sleep/zsaa072
Morin CM, Jarrin DC (2022) Epidemiology of insomnia: prevalence, course, risk factors, and public health burden. Sleep Med Clin 17(2):173–191. https://doi.org/10.1016/j.jsmc.2022.03.003
Mann C, Gorai S, Staubach-Renz P, Goldust M (2023) Sleep disorders in dermatology—a comprehensive review. J Dtsch Dermatol Ges 21(6):577–584. https://doi.org/10.1111/ddg.14992
Morin CM, Belleville G, Bélanger L, Ivers H (2011) The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 34(5):601–608. https://doi.org/10.1093/sleep/34.5.601
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28(2):193–213. https://doi.org/10.1016/0165-1781(89)90047-4
Gupta MA, Gupta AK (2013) Sleep-wake disorders and dermatology. Clin Dermatol 31(1):118–126. https://doi.org/10.1016/j.clindermatol.2011.11.016
Darsow U, Scharein E, Simon D, Walter G, Bromm B, Ring J (2001) New aspects of itch pathophysiology: component analysis of atopic itch using the ’Eppendorf Itch Questionnaire’. Int Arch Allergy Immunol 124(1):326–331. https://doi.org/10.1159/000053748
Thorburn PT, Riha RL (2010) Skin disorders and sleep in adults: where is the evidence? Sleep Med Rev 14(6):351–358. https://doi.org/10.1016/j.smrv.2009.12.001
Patel T, Ishiuji Y, Yosipovitch G (2007) Nocturnal itch: why do we itch at night? Acta Derm Venereol 87:295–298. https://doi.org/10.2340/00015555-0280
Fang H, Tu S, Sheng J, Shao A (2019) Depression in sleep disturbance: a review on a bidirectional relationship, mechanisms and treatment. J Cell Mol Med 23(4):2324–2332. https://doi.org/10.1111/jcmm.14170
Meltzer LJ, Flewelling KD, Jump S, Gyorkos E, White M, Hauk PJ (2020) Impact of atopic dermatitis treatment on child and parent sleep, daytime functioning, and quality of life. Ann Allergy Asthma Immunol 124(4):385–392. https://doi.org/10.1016/j.anai.2019.12.024
Moore K, David TJ, Murray CS, Child F, Arkwright PD (2006) Effect of childhood eczema and asthma on parental sleep and well-being: a prospective comparative study. Br J Dermatol 154(3):514–518. https://doi.org/10.1111/j.1365-2133.2005.07082.x
Bloch KE, Schoch OD, Zhang JN, Russi EW (1999) German version of the Epworth sleepiness scale. Respiration 66(5):440–447. https://doi.org/10.1159/000029408
Arumugam V, MacDermid JC (2013) The work limitations questionnaire (WLQ-25). J Physiother 59(4):276. https://doi.org/10.1016/s1836-9553(13)70210-8
Grandner MA, Jackson NJ, Pak VM, Gehrman PR (2012) Sleep disturbance is associated with cardiovascular and metabolic disorders. J Sleep Res 21(4):427–433. https://doi.org/10.1111/j.1365-2869.2011.00990.x
Rangel SM, Kim T, Sheth A et al (2023) Prevalence and associations of fatigue in childhood atopic dermatitis: a cross-sectional study. J Eur Acad Dermatol Venereol 37(4):763–771. https://doi.org/10.1111/jdv.18819
Ding W, Yang L, Shi E et al (2023) The endocannabinoid N‑arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption. Nat Commun 14(1):6696. https://doi.org/10.1038/s41467-023-42283-6
Li MT, Robinson CL, Ruan QZ, Surapaneni S, Southerland W (2022) The influence of sleep disturbance on chronic pain. Curr Pain Headache Rep 26(10):795–804. https://doi.org/10.1007/s11916-022-01074-2
Saconi B, Polomano RC, Compton PC, McPhillips MV, Kuna ST, Sawyer AM (2021) The influence of sleep disturbances and sleep disorders on pain outcomes among veterans: a systematic sco** review. Sleep Med Rev 56:101411. https://doi.org/10.1016/j.smrv.2020.101411
Frohnhofen H (2018) Pain and sleep : a bidirectional relationship. Z Gerontol Geriatr 51(8):871–874. https://doi.org/10.1007/s00391-018-01461-8
Sanders KM, Hashimoto T, Sakai K, Akiyama T (2018) Modulation of itch by localized skin warming and cooling. Acta Derm Venereol 98(9):855–861. https://doi.org/10.2340/00015555-2990
Meltzer E, Filho N, Bever H, Lucio L (2021) Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis. Allergy Asthma Clin Immunol. https://doi.org/10.1186/s13223-021-00614-6
Mann C, Wegner J, Weeß HG, Staubach P (2022) Pathobiology of second-generation antihistamines related to sleep in urticaria patients. Biology. https://doi.org/10.3390/biology11030433
Zandonai T, Lugoboni F, Zamboni L (2021) Benzodiazepine addiction: other factor to be considered in sleep among athletes. Sleep Med 78:7. https://doi.org/10.1016/j.sleep.2020.12.008
Baranwal N, Yu PK, Siegel NS (2023) Sleep physiology, pathophysiology, and sleep hygiene. Prog Cardiovasc Dis 77:59–69. https://doi.org/10.1016/j.pcad.2023.02.005
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
C. Mann und P. Staubach geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autorinnen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Hinweis des Verlags
Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.
![figure qr](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00105-024-05373-0/MediaObjects/105_2024_5373_Figqr_HTML.png?s=1)
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Mann, C., Staubach, P. Lebens- und Schlafqualität bei Patienten mit chronischem Pruritus. Dermatologie (2024). https://doi.org/10.1007/s00105-024-05373-0
Accepted:
Published:
DOI: https://doi.org/10.1007/s00105-024-05373-0